linkedin post 2015-08-01 05:17:15

Uncategorized
THE PROMISE OF POOP. "Gastroenterologist Thomas Borody...who since 1988 has performed fecal transplants in more than 3000 patients, suffering not just from C. difficile but also from irritable bowel syndrome; inflammatory bowel syndrome; constipation; arthritis; and sacroiliitis, an inflammation of the sacroiliac joint." https://lnkd.in/ebyCPji View in LinkedIn
Read More

linkedin post 2015-08-01 05:12:10

Uncategorized
AN OLD THERAPY COMES OF AGE. Impediments to FMT include: "It is aesthetically unappealing, it is logistically challenging (in terms of harvesting and processing suitable donor material), and there is a lack of efficacy data from randomized, controlled trials." https://lnkd.in/e92WcxV View in LinkedIn
Read More

linkedin post 2015-08-02 05:25:06

Uncategorized
"SYSTEMATIC REVIEW: faecal microbiota transplantation in the management of inflammatory bowel disease. Whilst the available evidence is limited and weak, it suggests that faecal microbiota transplantation has the potential to be an effective and safe treatment for IBD, at least when standard treatments have failed. Well-designed randomised controlled trials are required to investigate these findings." https://lnkd.in/edRQD5H View in LinkedIn
Read More

linkedin post 2015-08-02 05:20:21

Uncategorized
FECAL TRANSPLANTS (FMT). "The rationale behind FMT is simple: antibiotics and other factors disrupt the normal balance of colonic flora and reduce "colonization resistance", allowing pathogenic C. Difficle strains to grow...by reintroducing flora via donor feces, the imbalance can be corrected, the cycle interrupted, and normal bowel function re-established." https://lnkd.in/erygCxw View in LinkedIn
Read More

linkedin post 2015-08-02 05:17:23

Uncategorized
C. DIFFICILE FMT REVIEW. "In 317 patients treated across 27 case series and reports, FMT was highly effective, showing disease resolution in 92% of cases. Effectiveness varied by route of instillation, relationship to stool donor, volume of FMT given, and treatment before infusion. Death and adverse events were uncommon." https://lnkd.in/eymWM_R View in LinkedIn
Read More